Bliss GVS Pharma Limited has made a regulatory disclosure to the National Stock Exchange of India Ltd. and BSE Limited regarding the allotment of shares under its Employee Stock Option Plan (ESOP).

Key Event Details

  • Event Date: The ESOP Allotment Committee meeting was held and the allotment was approved on July 07, 2026.
  • Plan: Bliss GVS Pharma Limited–Employee Stock Option Plan, 2019 (Bliss GVS ESOP-2019).
  • Allotment Details: The committee approved the allotment of 1,87,750 equity shares of face value Re. 1/- each to an eligible employee who exercised their stock options.

Capital Structure Impact

Consequent to the allotment, the company's issued, subscribed, and paid-up share capital has increased as follows:

  • Pre-allotment: 10,60,56,223 equity shares aggregating to ₹10,60,56,223.
  • Post-allotment: 10,62,43,972 equity shares aggregating to ₹10,62,43,972.
  • This represents an increase of 187,749 shares and ₹187,749 in paid-up capital.

Share Specifics (From Annexure-I)

  • Security Type: Equity Shares
  • Par Value: Re. 1/- per share
  • Date of Issue: July 07, 2026
  • Number of Shares Issued: 1,87,750
  • Distinctive Numbers: 10,60,56,223 to 10,62,43,972 (both inclusive)
  • Exercise Price: ₹43 per share
  • Premium: ₹42 per share
  • Lock-in: The shares are subject to a lock-in period of 6 (six) months from the date of allotment, expiring on January 06, 2027.
  • Rights: The allotted shares are identical in all respects and will rank pari passu with the existing equity shares of the company.

Regulatory Background

  • The statement referred to in regulation 10(b) was filed with the recognized stock exchanges on February 14, 2020.
  • BSE Application No.: 106063
  • NSE Application No.: 23188
  • BSE In-Principle Approval: DCS/FL/DS/ESOP-IP/542/2019-20 dated February 27, 2020
  • NSE In-Principle Approval: NSE/LIST/23188 dated March 04, 2020

Financial Impact

The transaction results in a cash inflow for the company amounting to ₹80,73,250 (1,87,750 shares * ₹43 per share).

Filing and Signatory

The letter was digitally signed by Aditi Himanshu Bhatt, Company Secretary, on July 07, 2026, at 17:23:05 IST.